tetano
Editor, Senior Moderator
Dermatol Ther
. 2020 Nov 3;e14502.
doi: 10.1111/dth.14502. Online ahead of print.
Chilblains-like lesions and SARS-CoV-2 in children: an overview in therapeutic approach
Piero Pavone[SUP] 1 [/SUP], Silvia Marino[SUP] 2 [/SUP], Lidia Marino[SUP] 3 [/SUP], Giovanni Cacciaguerra[SUP] 3 [/SUP], Claudio Guarneri[SUP] 4 [/SUP], Giuseppe Nunnari[SUP] 4 [/SUP], Rosaria Taibi[SUP] 5 [/SUP], Livia Marletta[SUP] 4 [/SUP], Raffaele Falsaperla[SUP] 2 6 [/SUP]
Affiliations
Abstract
SARS-CoV-2 (Severe Acute Respiratory Syndrome, Coronavirus, type 2) is the virus responsible for the global pandemic of Coronavirus disease 2019 (COVID-19) that began in China in December 2019. The variability of nasal olfactory symptoms in pediatric patients is interlinked with possible warning signs, including respiratory, gastrointestinal, ocular, or dermatological symptoms. Skin findings in patients with COVID-19 can range from petechiae to papulovesicular rashes to diffuse urticaria and can be confused with rashes of non-COVID-19 conditions. These lesions typically appear early during COVID-19 and are thought to be secondary to viral replication or circulating cytokines. Herein we discuss two pediatric cases, presenting with skin lesions, which tested positive for SARS-CoV-2, thus, briefly reviewing current literature for similar reports and related management. Although these lesions heal spontaneously in most cases, an adequate "targeted" therapeutic approach can shorten the time and the discomfort of the skin disease. This article is protected by copyright. All rights reserved.
Keywords: Coronavirus; SARS-CoV-2 = Severe Acute Respiratory Syndrome; Therapy; type 2; 31 COVID 19 = Coronavirus disease 2019.
. 2020 Nov 3;e14502.
doi: 10.1111/dth.14502. Online ahead of print.
Chilblains-like lesions and SARS-CoV-2 in children: an overview in therapeutic approach
Piero Pavone[SUP] 1 [/SUP], Silvia Marino[SUP] 2 [/SUP], Lidia Marino[SUP] 3 [/SUP], Giovanni Cacciaguerra[SUP] 3 [/SUP], Claudio Guarneri[SUP] 4 [/SUP], Giuseppe Nunnari[SUP] 4 [/SUP], Rosaria Taibi[SUP] 5 [/SUP], Livia Marletta[SUP] 4 [/SUP], Raffaele Falsaperla[SUP] 2 6 [/SUP]
Affiliations
- PMID: 33141476
- DOI: 10.1111/dth.14502
Abstract
SARS-CoV-2 (Severe Acute Respiratory Syndrome, Coronavirus, type 2) is the virus responsible for the global pandemic of Coronavirus disease 2019 (COVID-19) that began in China in December 2019. The variability of nasal olfactory symptoms in pediatric patients is interlinked with possible warning signs, including respiratory, gastrointestinal, ocular, or dermatological symptoms. Skin findings in patients with COVID-19 can range from petechiae to papulovesicular rashes to diffuse urticaria and can be confused with rashes of non-COVID-19 conditions. These lesions typically appear early during COVID-19 and are thought to be secondary to viral replication or circulating cytokines. Herein we discuss two pediatric cases, presenting with skin lesions, which tested positive for SARS-CoV-2, thus, briefly reviewing current literature for similar reports and related management. Although these lesions heal spontaneously in most cases, an adequate "targeted" therapeutic approach can shorten the time and the discomfort of the skin disease. This article is protected by copyright. All rights reserved.
Keywords: Coronavirus; SARS-CoV-2 = Severe Acute Respiratory Syndrome; Therapy; type 2; 31 COVID 19 = Coronavirus disease 2019.